Sign in

CIK 0001640266

  • Accelerated filer
  • Smaller reporting company

Voyager Therapeutics, Inc.

Sign in to watch
Ticker
VYGR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 857-259-5340
Business address
75 HAYDEN AVENUE, LEXINGTON, MA, 02421
  1. 3 Insider Initial Statement of Ownership
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Grant or award Chief Medical Officer acquired 105,000 shares (grant or award)
  12. 4 Open-market sale Chief Operating Officer sold 1,357 shares at $9.88 ($13,407)
  13. 4 Open-market sale President and CEO sold 12,115 shares at $9.86 ($119,454)
  14. 4 Derivatives Options or other derivatives
  15. 3 Insider Initial Statement of Ownership
  16. 4 Open-market sale Chief Operating Officer sold 3,966 shares at $7.45 ($29,547)
  17. 4 Open-market sale President and CEO sold 13,033 shares at $7.46 ($97,226)
  18. 4 Open-market sale Chief Financial Officer sold 3,764 shares at $7.46 ($28,079)
  19. 4 Open-market sale Chief Scientific Officer sold 3,967 shares at an average $7.50 ($29,760)
  20. 4 Grant or award Chief Legal Officer acquired 31,000 shares (grant or award)

Page 4 of 16 · 312 filings